Helius Medical Technologies Inc HSDT

Healthcare Medical Devices

Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. It develops, licenses, or acquires non-implantable technologies targeted at reducing symptoms of neurological disease or trauma. Its product Portable Neuromodulation Stimulator (PoNS) is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy is integral to the overall PoNS solution and is the physical therapy applied by patients during use of the PoNS neuromodulation stimulator. PoNS is used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only.

NDAQ:HSDT - Post by User

Helius Medical Technologies Inc

Bullboard Posts

Comment by prokofievon Nov 23, 2018 9:16am

105 Views

Post# 29013177

RE:RE:RE:RE:RE:RE:BTIG upgrading HSDT to Buy with a $14 PT

When you say "non-financiers", do you mean a strategic acquierer such as a Medtronic?

Prokofiev

ShakesPeer wrote: I agree with macygirl17. There is a plan in place and virtually no denying that this device will provide amazing results which will be revealed theough proper marketing (post FDA approval) and then followed by actual revenue/profit benchmarks analysis. But it also begs the question as to what a ‘non-financiers’ analysis would currently look like as well??

Bullboard Posts

Morning Market Outlook for May 22, 2024